ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 34 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,941 | +0.7% | 60,514 | +38.2% | 0.00% | – |
| Q2 2023 | $156,768 | -74.7% | 43,790 | -84.6% | 0.00% | – |
| Q1 2023 | $619,417 | -83.7% | 284,136 | -10.2% | 0.00% | – |
| Q4 2022 | $3,806,183 | +11.4% | 316,391 | -40.0% | 0.00% | – |
| Q3 2022 | $3,416,000 | +8.6% | 527,106 | -23.3% | 0.00% | – |
| Q2 2022 | $3,145,000 | -38.8% | 686,851 | +15.6% | 0.00% | -100.0% |
| Q1 2022 | $5,139,000 | -6.9% | 594,028 | +53.6% | 0.00% | 0.0% |
| Q4 2021 | $5,520,000 | +109.3% | 386,620 | +222.2% | 0.00% | – |
| Q3 2021 | $2,637,000 | +138.2% | 120,005 | +45.2% | 0.00% | – |
| Q2 2021 | $1,107,000 | +708.0% | 82,666 | +514.3% | 0.00% | – |
| Q1 2021 | $137,000 | +291.4% | 13,456 | +63.8% | 0.00% | – |
| Q4 2020 | $35,000 | +133.3% | 8,216 | +43.1% | 0.00% | – |
| Q3 2020 | $15,000 | -34.8% | 5,741 | -12.9% | 0.00% | – |
| Q2 2020 | $23,000 | +21.1% | 6,595 | +2.5% | 0.00% | – |
| Q1 2020 | $19,000 | -84.2% | 6,436 | -72.2% | 0.00% | – |
| Q4 2019 | $120,000 | +22.4% | 23,175 | -24.7% | 0.00% | – |
| Q3 2019 | $98,000 | -3.0% | 30,797 | +9.0% | 0.00% | – |
| Q2 2019 | $101,000 | +4.1% | 28,252 | +5.8% | 0.00% | – |
| Q1 2019 | $97,000 | +14.1% | 26,701 | -6.0% | 0.00% | – |
| Q4 2018 | $85,000 | -40.6% | 28,394 | -3.5% | 0.00% | – |
| Q3 2018 | $143,000 | -34.7% | 29,434 | -0.0% | 0.00% | – |
| Q2 2018 | $219,000 | -0.5% | 29,439 | -13.1% | 0.00% | – |
| Q1 2018 | $220,000 | -32.1% | 33,887 | -5.9% | 0.00% | – |
| Q4 2017 | $324,000 | +120.4% | 35,994 | +143.8% | 0.00% | – |
| Q3 2017 | $147,000 | +50.0% | 14,766 | +16.9% | 0.00% | – |
| Q2 2017 | $98,000 | -38.8% | 12,635 | -51.5% | 0.00% | – |
| Q1 2017 | $160,000 | -17.5% | 26,064 | -17.8% | 0.00% | – |
| Q4 2016 | $194,000 | +65.8% | 31,720 | +97.8% | 0.00% | – |
| Q3 2016 | $117,000 | -63.6% | 16,039 | -58.3% | 0.00% | – |
| Q2 2016 | $321,000 | +1184.0% | 38,492 | +910.6% | 0.00% | – |
| Q1 2016 | $25,000 | -10.7% | 3,809 | +15.1% | 0.00% | – |
| Q4 2015 | $28,000 | -6.7% | 3,309 | -40.9% | 0.00% | – |
| Q3 2015 | $30,000 | +15.4% | 5,595 | +23.7% | 0.00% | – |
| Q2 2015 | $26,000 | +8.3% | 4,522 | +21.6% | 0.00% | – |
| Q1 2015 | $24,000 | -33.3% | 3,718 | -52.5% | 0.00% | – |
| Q4 2014 | $36,000 | -51.4% | 7,823 | -15.1% | 0.00% | – |
| Q3 2014 | $74,000 | -42.6% | 9,215 | -31.1% | 0.00% | – |
| Q2 2014 | $129,000 | -58.4% | 13,373 | -49.1% | 0.00% | – |
| Q1 2014 | $310,000 | +68.5% | 26,297 | +120.2% | 0.00% | – |
| Q4 2013 | $184,000 | – | 11,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
| Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
| Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
| Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
| XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
| Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
| Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
| ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
| Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |